Investigators determined if patient-derived organoids (PDOs) could be used to personalize poly-chemotherapy regimens by pharmacotyping of treatment-naïve and post neoadjuvant chemotherapy PDAC PDOs.
[Journal of Pathology]
Sorry, but the selected Zotpress account can't be found.